Search for: "Abbott v. Abbott" Results 741 - 760 of 2,554
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Apr 2017, 8:35 am
Section V then posits an alternative analysis, normatively autonomous (though not entirely free) of the orbit of the state, a vision possible only when the ideological presumptions of the state are suspended. [read post]
4 Apr 2017, 3:47 pm by Abbott & Kindermann
Abbott, Diane Kindermann, Glen Hansen, Brian Russell and Dan Cucchi Welcome to Abbott & Kindermann’s 2017 1st Quarter CEQA update. [read post]
3 Apr 2017, 2:22 pm by Lawrence B. Ebert
See Abbott Labs. v.Sandoz, Inc., 566 F.3d 1282, 1299 (Fed. [read post]
30 Mar 2017, 9:30 am by Sandy Levinson
  I was happy, in a debate at the University of Texas Law School, to offer one cheer for Texas Governor Greg Abbott, who has endorsed a new convention and offered his ambitious nine-point “Texas plan” to reform our flawed document. [read post]
14 Mar 2017, 6:01 pm by Bill Marler
An Article I wrote in 2001 Bill Neuman wrote yet another article on cheese – “Raw Milk Cheesemakers Fret Over Possible New Rules” – after Food Safety News reported it and in follow-up to my five part series on raw milk and the “60 day rule” – Part 1, Part 2, Part 3, Part 4 and Part 5, and the continuing outbreaks, illnesses and recalls linked to raw (unpasteurized) and pasteurized dairy products in the United… [read post]
10 Mar 2017, 6:50 am by Brian Cordery
Nevertheless, having considered the chain of title and following Edwards Lifesciences v Cook Biotech [2009] EWHC 1340 (Pat), in which the court held that to make a valid claim for priority as successor in title it is necessary to be a successor in title at the time of filing the application, and KCI v Smith & Nephew [2010] EWHC 1487 (Pat), in which the court held that “successor in title” includes a person who was a recipient of the beneficial interest in the… [read post]
“Specialty drugs” are a fast growing sector of the pharmaceutical industry and are predicated to represent 50 percent of drug expenditures in the United States by 2020.[1] Specialty drugs are typically dispensed by specialty pharmacies. [read post]